CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.

CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.

CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.

Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.

CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.

Endometriosis surgery involves the removal or reduction of endometrial-like tissue outside the uterus to alleviate symptoms and improve quality of life.

A positive result indicates past infection with the Dengue virus or successful vaccination against Dengue.

No, additional tests, such as Dengue IgM or PCR, may be required to differentiate recent infections from past ones.

No, the Dengue IgG test is not suitable for diagnosing acute Dengue infection. IgG antibodies appear later in the course of infection.

Dengue IgG antibodies can remain detectable in the bloodstream for months to years after infection or vaccination.

A negative result suggests no detectable Dengue IgG antibodies. If symptoms persist or there is a recent exposure, consult a healthcare provider for further evaluation.